Clinical trial Recruiting at 1 site Observational Ages 18 and up

Early stratification of acute arthritis

Official title: Early STratification of Acute ARThritis (START)- A Prospective Observational Study

Run by Diakonhjemmet Hospital · NCT07106931 · Data updated 2026-11-12

The project will collect clinical information and biomarker samples to try to find signs that help classify and guide treatment for adults who developed inflammatory arthritis symptoms within the past 12 weeks.

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment400 (estimated)
SponsorDiakonhjemmet Hospital
Academic / other
Locations1 site (Oslo)
StatusRecruiting
StartedNovember 5, 2024
Main results expectedDecember 31, 2044
Study endsDecember 31, 2044
Registry record updatedAugust 6, 2025
Trial IDNCT07106931 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (over 18) with clinically active synovitis in at least one joint of less than 12 weeks' duration who can provide informed consent are eligible candidates.

Probably not a fit

People whose swelling is clearly due to trauma, those with symptoms longer than 12 weeks, children under 18, or individuals unable to follow the protocol are unlikely to receive direct benefit from participation.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

START is a prospective observational cohort enrolling adults with active synovitis of less than 12 weeks to build a platform for biomarker discovery and validation. Participants receive standardized clinical evaluation, possible ultrasound confirmation, and collection of biological samples without any experimental treatments. The effort aims to identify markers that distinguish types of inflammatory joint disease, detect infection, and predict the most appropriate initial management. Results from a large, well-characterized patient sample will be used to develop tools for earlier diagnosis and more personalized therapy.

Why it matters

Potential benefit: If successful, the platform could enable earlier, more accurate diagnosis and help clinicians choose the right initial treatment tailored to each patient's type of arthritis.

How similar studies have gone: Previous early arthritis cohorts and biomarker studies have produced promising leads but have not yet delivered widely adopted clinical stratification tools, so this work builds on encouraging but incomplete evidence.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Arthritis\* in one or more joints of less than 12 weeks' duration\*\*
* Adult patients (\> 18 years) capable of understanding and signing an informed consent form

  * Defined as currently active clinical synovitis (ie, swelling) in at least one joint as determined by an expert assessor which might be confirmed by ultrasonography \*\* Prior patient reported swollen joint not confirmed as arthritis by a rheumatologist is not an exclusion

Exclusion Criteria:

* Swollen joint related to trauma
* Subject not capable of adhering to the study protocol

Where it's running

  • Diakonhjemmet Hospital
    Oslo, Norway
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.